eISSN: 1897-4309
ISSN: 1428-2526
Contemporary Oncology/Współczesna Onkologia
Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications
4/2024
vol. 28
 
Share:
Send email
Share:
Original paper

NBAT1/miR-21 axis in progression of colorectal cancer and impact of PVT-1 polymorphism on miR-145 expression level and its clinical significance

Ghada Ayeldeen
1
,
Ahmed K. Zaki
2
,
Eman Amer
3
,
Zeinab Abdellatif
4
,
Olfat G. Shaker
1
,
Mohamed Said
5
,
Amr M. Abdelhamid
5

  1. Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Cairo University, Cairo, Egypt
  2. Department of Clinical and Chemical Pathology, National Cancer Institute, Cairo University, Cairo, Egypt
  3. Department of Biochemistry, Faculty of Pharmacy, Ahram Canadian University, Egypt
  4. Department of Endemic Medicine, Faculty of Medicine, Cairo University, Cairo, Egypt
  5. Department of Biochemistry, Faculty of Pharmacy, October University for Modern Sciences and Arts (MSA), 6th of October, Egypt
Contemp Oncol (Pozn) 2024; 28 (4): 304–317
DOI: https://doi.org/10.5114/wo.2024.146961
Online publish date: 2025/01/15
Article file
- NBAT1 miR-21 axis.pdf  [0.60 MB]
Get citation
 
PlumX metrics:
 
1. Requena DO, Garcia-Buitrago M. Molecular insights into colorectal carcinoma. Arch Med Res 2020; 51: 839-844.
2. He Q, Long J, Yin Y, Li Y, Lei X, Li Z, Zhu W. Emerging roles of lncRNAs in the formation and progression of colorectal cancer. Front Oncol 2019; 9: 1542.
3. Ayeldeen G, Shaker OG, Amer E, Zaafan MA, Herzalla MR, Keshk MA, Abdelhamid AM. The Impact of lncRNA-GAS5/miRNA-200/ACE2 Molecular Pathway on the Severity of COVID-19. Curr Med Chem 2024; 31: 1142-1151.
4. Guo M, Li X, Li J, Li B. Identification of the prognostic biomarkers and their correlations with immune infiltration in colorectal cancer through bioinformatics analysis and in vitro experiments. Heliyon 2023; 9: e17101.
5. Sun G, Li Y, Peng Y, et al. Identification of differentially expressed genes and biological characteristics of colorectal cancer by integrated bioinformatics analysis. J Cell Physiol 2019; 234: 15215-15224.
6. Li KZ, Yin YX, Tang YP, et al. Construction of a long noncoding RNA-based competing endogenous RNA network and prognostic signatures of left- and right-side colon cancer. Cancer Cell Int 2021; 21: 211.
7. Li J, Zhang H, Gao F. Identification of miRNA biomarkers for breast cancer by combining ensemble regularized multinomial logistic regression and Cox regression. BMC Bioinformatics 2022; 23: 434.
8. Jin K, Wang S, Zhang Y, et al. Long non-coding RNA PVT1 interacts with MYC and its downstream molecules to synergistically promote tumorigenesis. Cell Mol Life Sci 2019; 76: 4275-4289.
9. Zai H, Wu X, Zhou Y, Hu Y, Zhu Q. Lnc NBAT1 Inhibits the proliferation and migration of liver cancer cells through the miR-21/PDCD4/AP-1 signaling axis. Appl Biochem Biotechnol 2025; 197: 1-18.
10. Yu Y, Fan K, Ni T, Zhang XL, Su X, Yang L. Expression level and clini­cal significance of NBAT-1 in human cancers: a systematic review and meta-analysis. BMC Cancer 2024; 24: 109.
11. Ogunwobi OO, Mahmood F, Akingboye A. Biomarkers in colorectal cancer: current research and future prospects. Int J Mol Sci 2020; 21: 5311.
12. Park JH, Jin EH, Hong JH, Lee SI, Sung JK. The association between polymorphism of the long noncoding RNA, Plasmacytoma variant translocation 1, and the risk of gastric cancer. Medicine (Baltimore) 2021; 100: e27773.
13. Juvvuna PK, Mondal T, Di Marco M, Kosalai ST, Kanduri M, Kanduri C. NBAT1/CASC15-003/USP36 control MYCN expression and its downstream pathway genes in neuroblastoma. Neurooncology Adv 2021; 3: vdab056.
14. Abdel-Nasser ZM, Zaafan MA, Abdelhamid AM. Modulation of the miR-122/Sirt-6/ACE2 axis on experimentally-induced myocardial infarction. Chem Biol Interact 2023; 369: 110276.
15. Pu M, Chen J, Tao Z, Miao L, Qi X, Wang Y, Ren J. Regulatory network of miRNA on its target: coordination between transcriptional and post-transcriptional regulation of gene expression. Cell Mol Life Sci 2019; 76: 441-451.
16. Shaker O, Ayeldeen G, Abdelhamid A. The impact of single nucleotide polymorphism in the long non-coding MEG3 gene on micro­RNA-182 and microRNA-29 expression levels in the development of breast cancer in Egyptian women. Front Genet 2021; 12: 683809.
17. Elfert AY, Salem A, Abdelhamid AM, Salama A, Sourour DA, Shaker O, Keshk M. Implication of miR-122, miR-483, and miR-335 Expression levels as potential signatures in HCV-related hepatocellular carcinoma (HCC) in Egyptian patients. Front Mol Biosci 2022; 9: 864839.
18. Lekka E, Hall J. Noncoding RNAs in disease. FEBS Lett 2018; 592: 2884-2900.
19. Yuan Y, Haiying G, Zhuo L, Ying L, Xin H. Long non-coding RNA LINC00339 facilitates the tumorigenesis of non-small cell lung cancer by sponging miR-145 through targeting FOXM1. Biomed Pharmacother 2018; 105: 707-713.
20. Zhang H, Jiang M, Liu Q, Han Z, Zhao Y, Ji S. miR-145-5p inhibits the proliferation and migration of bladder cancer cells by targeting TAGLN2. Oncol Lett 2018; 16: 6355-6360.
21. Qi X, Zhang DH, Wu N, Xiao JH, Wang X, Ma W. ceRNA in cancer: possible functions and clinical implications. J Med Genet 2015; 52: 710-718.
22. Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 2010; 17: 1471-1474.
23. Snipstad K, Fenton CG, Kjaeve J, Cui G, Anderssen E, Paulssen RH. New specific molecular targets for radio-chemotherapy of rectal cancer. Mol Oncol 2010; 4: 52-64.
24. Ogata-Kawata H, Izumiya M, Kurioka D, et al. Circulating exosomal microRNAs as biomarkers of colon cancer. PLoS One 2014; 9: e92921.
25. Yamada A, Yu P, Lin W, Okugawa Y, Boland CR, Goel A. A RNA- sequencing approach for the identification of novel long non- coding RNA biomarkers in colorectal cancer. Sci Rep 2018; 8: 575.
26. Ashburner M, Ball CA, Blake JA, et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 2000; 25: 25-29.
27. Ge SX, Jung D, Yao R. ShinyGO: a graphical gene-set enrichment tool for animals and plants. Bioinformatics 2020; 36: 2628-2629.
28. Kanehisa M, Goto S, Kawashima S, Okuno Y, Hattori M. The KEGG resource for deciphering the genome. Nucleic Acids Res 2004; 32 (Database issue): D277-D280.
29. Sticht C, De La Torre C, Parveen A, Gretz N. miRWalk: an online resource for prediction of microRNA binding sites. PLoS One 2018; 13: e0206239.
30. Jeggari A, Marks DS, Larsson E. miRcode: a map of putative microRNA target sites in the long non-coding transcriptome. Bioinformatics 2012; 28: 2062-2063.
31. Yang Y, Wang D, Miao YR, et al. lncRNASNP v3: an updated database for functional variants in long non-coding RNAs. Nucleic Acids Res 2023; 51(D1): D192-D198.
32. Guo LL, Song CH, Wang P, Dai LP, Zhang JY, Wang KJ. Competing endogenous RNA networks and gastric cancer. World J Gastroenterol 2015; 21: 11680-11687.
33. Xu Y, Chen J, Yang Z, Xu L. Identification of RNA expression profiles in thyroid cancer to construct a competing endogenous RNA (ceRNA) Network of mRNAs, Long Noncoding RNAs (lncRNAs), and microRNAs (miRNAs). Med Sci Monit 2019; 25: 1140-1154.
34. Demchak B, Hull T, Reich M, Liefeld T, Smoot M, Ideker T, Mesirov JP. Cytoscape: the network visualization tool for GenomeSpace workflows. F1000Res 2014; 3: 151.
35. Fabian MR, Sonenberg N, Filipowicz W. Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem 2010; 79: 351-379.
36. Shaker OG, Ayeldeen G, Abdelhamid AM. Circulating microRNA- 944 and its target gene EPHA7 as a potential biomarker for colorectal cancer. Arch Physiol Biochem 2022; 128: 1181-1187.
37. Zaafan MA, Abdelhamid AM. Molecular insight of miRNA-217 role in the pathogenesis of myocardial infarction: promising diagnostic biomarker and therapeutic target. Noncoding RNA Res 2024; 10: 192-197.
38. Wu H, Wei M, Jiang X, et al. lncRNA PVT1 Promotes Tumorigenesis of Colorectal Cancer by Stabilizing miR-16-5p and Interacting with the VEGFA/VEGFR1/AKT Axis. Mol Ther Nucleic Acids 2020; 20: 438-450.
39. Elfert AY, Salem A, Abdelhamid AM, Salama A, Sourour DA, Shaker O, Keshk MJFiMB. Implication of miR-122, miR-483, and miR-335 expression levels as potential signatures in HCV-related hepatocellular carcinoma (HCC) in Egyptian patients. Front Mol Biosci 2022; 9: 864839.
40. Zaafan MA, Abdelhamid AM. Dasatinib ameliorates thioacetamide-induced liver fibrosis: modulation of miR-378 and miR-17 and their linked Wnt/-catenin and TGF-/smads pathways. J Enzyme Inhib Med Chem 2022; 37: 118-124.
41. Ogunwobi OO, Mahmood F, Akingboye A. Biomarkers in colorectal cancer: current research and future prospects. Int J Mol Sci 2020; 21: 5311.
42. He RQ, Qin MJ, Lin P, et al. Prognostic significance of LncRNA PVT1 and its potential target gene network in human cancers: a comprehensive inquiry based upon 21 cancer types and 9972 cases. Cell Physiol Biochem 2018; 46: 591-608.
43. Zheng C, Xiao Y, Li Y, He D. Knockdown of long non coding RNA PVT1 inhibits the proliferation of Raji cells through cell cycle regulation. Oncol Lett 2019; 18: 1225-1234.
44. Takahashi Y, Sawada G, Kurashige J, et al. Amplification of PVT-1 is involved in poor prognosis via apoptosis inhibition in colorectal cancers. Br J Cancer 2014; 110: 164-171.
45. Shigeyasu K, Toden S, Ozawa T, et al. The PVT1 lncRNA is a novel epigenetic enhancer of MYC, and a promising risk-stratification biomarker in colorectal cancer. Mol Cancer 2020; 19: 155.
46. Radwan AF, Shaker OG, El-Boghdady NA, Senousy MA. Association of MALAT1 and PVT1 variants, expression profiles and target miRNA- 101 and miRNA-186 with colorectal cancer: correlation with epithelial-mesenchymal transition. Int J Mol Sci 2021; 22: 6147.
47. Cerhan JR, Berndt SI, Vijai J, et al. Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma. Nat Genet 2014; 46: 1233-1238.
48. RezaSoltani M, Forouzesh F, Salehi Z, Zabihi MR, Rejali L, Nazemalhosseini-Mojarad E. Identification of LncPVT1 and CircPVT1 as prognostic biomarkers in human colorectal polyps. Sci Rep 2023; 13: 13113.
49. Wu S, Yang X, Tang W, Familiari G, Relucenti M, Aschner M, Li X, Chen R. Chemotherapeutic risk lncRNA-PVT1 SNP sensitizes meta­static colorectal cancer to FOLFOX regimen. Front Oncol 2022; 12: 808889.
50. Ding C, Yang Z, Lv Z, et al. Long non coding RNA PVT1 is associated with tumor progression and predicts recurrence in hepatocellular carcinoma patients. Oncol Lett 2015; 9: 955-963.
51. Ghafouri-Fard S, Omrani MD, Taheri M. Long noncoding RNA PVT1: a highly dysregulated gene in malignancy. J Cell Physiol 2020; 235: 818-835.
52. Wang Z, Su M, Xiang B, Zhao K, Qin B. Circular RNA PVT1 promotes metastasis via miR-145 sponging in CRC. Biochem Biophys Res Commun 2019; 512: 716-722.
53. Abdelhamid A, El Deeb M, Zaafan M. The protective effect of xanthenone against LPS-induced COVID-19 acute respiratory distress syndrome (ARDS) by modulating the ACE2/Ang-1-7 signaling pathway. Eur Rev Med Pharmacol Sci 2022; 26: 5285-5296.
54. Sheng N, Tan G, You W, et al. MiR-145 inhibits human colorectal cancer cell migration and invasion via PAK4-dependent pathway. Cancer Med 2017; 6: 1331-1340.
55. Jiang Y, Wang D, Ren H, Shi Y, Gao Y. MiR-145-targeted HBXIP modu­lates human breast cancer cell proliferation. Thorac Cancer 2019; 10: 71-77.
56. Li S, Wu X, Xu Y, et al. miR-145 suppresses colorectal cancer cell migration and invasion by targeting an ETS-related gene. J Oncol Rep 2016; 36: 1917-1926.
57. Yuan W, Sui C, Liu Q, Tang W, An H, Ma J. Up-regulation of micro­RNA-145 associates with lymph node metastasis in colorectal cancer. PLoS One 2014; 9: e102017.
58. Yin Y, Yan ZP, Lu NN, et al. Downregulation of miR-145 associated with cancer progression and VEGF transcriptional activation by targeting N-RAS and IRS1. Biochim Biophys Acta 2013; 1829: 239-247.
59. Tian C, Su J, Ma Z, Wu Y, Ma H. lncRNA NBAT1 inhibits cell metastasis and promotes apoptosis in endometrial cancer by sponging miR-21-5p to regulate PTEN. Comput Math Methods Med 2022; 2022: 9304392.
60. Lei T, Lv Z, Fu J, Wang Z, Fan Z, Wang Y. LncRNA NBAT-1 is down-regulated in lung cancer and influences cell proliferation, apoptosis and cell cycle. Eur Rev Med Pharmacol Sci 2018; 22: 1958-1962.
61. Yang C, Wang G, Yang J, Wang L. Long noncoding RNA NBAT1 negatively modulates growth and metastasis of osteosarcoma cells through suppression of miR-21. Am J Cancer Res 2017; 7: 2009.
62. Huang Y, Yang YB, Zhang XH, Yu XL, Wang ZB, Cheng XC. Micro­RNA-21 gene and cancer. Med Oncol 2013; 30: 376.
63. Kushlinskii N, Fridman M, Braga E. Long non-coding RNAs as competitive endogenous RNAs in osteosarcoma. Mol Biol 2020; 54: 684-707.
64. Ratti M, Lampis A, Ghidini M, Salati M, Mirchev MB, Valeri N, Hahne JC. MicroRNAs (miRNAs) and long non-coding RNAs (lncRNAs) as new tools for cancer therapy: first steps from bench to bedside. Target Oncol 2020; 15: 261-278.
Copyright: © 2025 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
FEATURED PRODUCTS
BOOKS
• Genetyka i leczenie chłoniaka rozlanego z dużych komórek B (DLBCL)
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2025 Termedia Sp. z o.o.
Developed by Bentus.